Intrinsic Value of S&P & Nasdaq Contact Us

BioLineRx Ltd. BLRX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • IL • USD

SharesGrow Score
51/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — BLRX

BioLineRx Ltd. (BLRX) has a market capitalization of $10.36M and trades at $2.38. The 52-week range is 2.15-7.77.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -8.2, Earnings Per Share (EPS) of $-0.29, annual revenue of $1.19M.

The stock has a beta of 0.48, operates in the Healthcare sector.

Trading Data
Current Price$2.38
52-Week Range2.15-7.77
Volume12.8K
Avg Volume (30D)14.75K
Market Cap$10.36M
Beta (1Y)0.48
Company
IPO Date2011-07-27
Employees28
CEOElla Sorani
CountryIL
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS09071M3043
CUSIP09071M304
Income (Latest Year)
Revenue$1.19M
Gross Profit$430.39K
EBITDA$-9.84M
Operating Income$-10.37M
Net Income$-1.18M
EPS$-0.29
EPS Diluted$-0.29
Shares Outstanding$4.11M
Balance Sheet (Latest Year)
Total Assets$40.9M
Current Assets$23.68M
Cash & ST Investments$20.88M
Total Liabilities$17.56M
Total Debt$10.15M
Net Debt$6.9M
Total Equity$23.34M
Debt / Equity0.43
Valuation Ratios
P/E Ratio-8.2
P/S Ratio8.71
P/B Ratio0.44
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message